Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 223

1.

Treatments for Fecal Incontinence [Internet].

Forte ML, Andrade KE, Butler M, Lowry AC, Bliss DZ, Slavin JL, Kane RL.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2016 Mar.

2.

Systematic Review of Surgical Treatments for Fecal Incontinence.

Forte ML, Andrade KE, Lowry AC, Butler M, Bliss DZ, Kane RL.

Dis Colon Rectum. 2016 May;59(5):443-69. doi: 10.1097/DCR.0000000000000594.

PMID:
27050607
3.

Shutting down the pore: The search for small molecule inhibitors of the mitochondrial permeability transition.

Šileikytė J, Forte M.

Biochim Biophys Acta. 2016 Feb 26. pii: S0005-2728(16)30035-4. doi: 10.1016/j.bbabio.2016.02.016. [Epub ahead of print]

PMID:
26924772
4.

Part 5: Unproven cell therapies and the commercialization of cell-based products.

Deans RJ, Gunter KC, Dominici M, Forte M.

Cytotherapy. 2016 Jan;18(1):138-42. doi: 10.1016/j.jcyt.2015.11.001. No abstract available.

PMID:
26719206
5.

N-Phenylbenzamides as Potent Inhibitors of the Mitochondrial Permeability Transition Pore.

Roy S, Šileikytė J, Neuenswander B, Hedrick MP, Chung TD, Aubé J, Schoenen FJ, Forte MA, Bernardi P.

ChemMedChem. 2016 Feb;11(3):283-8. doi: 10.1002/cmdc.201500545. Epub 2015 Dec 23.

PMID:
26693836
6.

Triclosan and bisphenol a affect decidualization of human endometrial stromal cells.

Forte M, Mita L, Cobellis L, Merafina V, Specchio R, Rossi S, Mita DG, Mosca L, Castaldi MA, De Falco M, Laforgia V, Crispi S.

Mol Cell Endocrinol. 2016 Feb 15;422:74-83. doi: 10.1016/j.mce.2015.11.017. Epub 2015 Nov 19.

PMID:
26604029
7.

Positioning a Scientific Community on Unproven Cellular Therapies: The 2015 International Society for Cellular Therapy Perspective.

Dominici M, Nichols K, Srivastava A, Weiss DJ, Eldridge P, Cuende N, Deans RJ, Rasko JE, Levine AD, Turner L, Griffin DL, O'Donnell L, Forte M, Mason C, Wagena E, Janssen W, Nordon R, Wall D, Ho HN, Ruiz MA, Wilton S, Horwitz EM, Gunter KC; 2013–2015 ISCT Presidential Task Force on Unproven Cellular Therapy.

Cytotherapy. 2015 Dec;17(12):1663-6. doi: 10.1016/j.jcyt.2015.10.007. No abstract available.

PMID:
26589750
8.

Polystyrene nanoparticles internalization in human gastric adenocarcinoma cells.

Forte M, Iachetta G, Tussellino M, Carotenuto R, Prisco M, De Falco M, Laforgia V, Valiante S.

Toxicol In Vitro. 2016 Mar;31:126-36. doi: 10.1016/j.tiv.2015.11.006. Epub 2015 Nov 14.

PMID:
26585375
9.

Bigger Data, Bigger Problems.

Slobogean GP, Giannoudis PV, Frihagen F, Forte ML, Morshed S, Bhandari M.

J Orthop Trauma. 2015 Dec;29 Suppl 12:S43-6. doi: 10.1097/BOT.0000000000000463.

PMID:
26584266
10.

Commentary: SPG7 is an essential and conserved component of the mitochondrial permeability transition pore.

Bernardi P, Forte M.

Front Physiol. 2015 Nov 4;6:320. doi: 10.3389/fphys.2015.00320. eCollection 2015. No abstract available.

11.

Sirtuins: a possible clinical implication in cardio- and cerebro- vascular systems.

Conti V, Forte M, Corbi G, Russomanno G, Formisano L, Landolfi A, Izzo V, Filippell A, Vecchione C, Carrizzo A.

Curr Drug Targets. 2015 Oct 18. [Epub ahead of print]

PMID:
26477463
12.

Discovery, Synthesis, and Optimization of Diarylisoxazole-3-carboxamides as Potent Inhibitors of the Mitochondrial Permeability Transition Pore.

Roy S, Šileikytė J, Schiavone M, Neuenswander B, Argenton F, Aubé J, Hedrick MP, Chung TD, Forte MA, Bernardi P, Schoenen FJ.

ChemMedChem. 2015 Oct;10(10):1655-71. doi: 10.1002/cmdc.201500284. Epub 2015 Aug 18.

13.

The Mitochondrial Permeability Transition Pore: Channel Formation by F-ATP Synthase, Integration in Signal Transduction, and Role in Pathophysiology.

Bernardi P, Rasola A, Forte M, Lippe G.

Physiol Rev. 2015 Oct;95(4):1111-55. doi: 10.1152/physrev.00001.2015. Review.

PMID:
26269524
14.

Expression and potential role of the peptide orexin-A in prostate cancer.

Valiante S, Liguori G, Tafuri S, Pavone LM, Campese R, Monaco R, Iachetta G, Assisi L, Mirabella N, Forte M, Costagliola A, Vittoria A.

Biochem Biophys Res Commun. 2015 Sep 4;464(4):1290-6. doi: 10.1016/j.bbrc.2015.07.124. Epub 2015 Jul 26.

PMID:
26220343
15.

Determinants of survival and major amputation after peripheral endovascular intervention for critical limb ischemia.

Vierthaler L, Callas PW, Goodney PP, Schanzer A, Patel VI, Cronenwett J, Bertges DJ; Vascular Study Group of New England.

J Vasc Surg. 2015 Sep;62(3):655-64.e8. doi: 10.1016/j.jvs.2015.04.391. Epub 2015 Jul 26.

PMID:
26215708
16.

Validation of a method for measuring (226)Ra in drinking waters by LSC.

Forte M, Abbate G, Badalamenti P, Costantino S, Lunesu D, Rusconi R.

Appl Radiat Isot. 2015 Sep;103:143-50. doi: 10.1016/j.apradiso.2015.05.022. Epub 2015 Jun 6.

PMID:
26093366
17.

Decisional Dilemmas in Discontinuing Prolonged Disease-Modifying Treatment for Multiple Sclerosis [Internet].

Butler M, Forte ML, Schwehr N, Carpenter A, Kane RL.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2015 Apr.

18.

Small Molecules Targeting the Mitochondrial Permeability Transition.

Sileikyte J, Roy S, Porubsky P, Neuenswander B, Wang J, Hedrick M, Pinkerton AB, Salaniwal S, Kung P, Mangravita-Novo A, Smith LH, Bourdette DN, Jackson MR, Aubé J, Chung TDY, Schoenen FJ, Forte MA, Bernardi P.

Probe Reports from the NIH Molecular Libraries Program [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2010-.
2014 Apr 15 [updated 2015 Jan 16].

19.

Curcumin loaded PLGA-poloxamer blend nanoparticles induce cell cycle arrest in mesothelioma cells.

Mayol L, Serri C, Menale C, Crispi S, Piccolo MT, Mita L, Giarra S, Forte M, Saija A, Biondi M, Mita DG.

Eur J Pharm Biopharm. 2015 Jun;93:37-45. doi: 10.1016/j.ejpb.2015.03.005. Epub 2015 Mar 17.

PMID:
25794477
20.

Treatments for Fibromyalgia in Adult Subgroups [Internet].

Forte ML, Butler M, Andrade KE, Vincent A, Schousboe JT, Kane RL.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2015 Jan.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk